Apex Labs Ltd.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://apexlabs.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
Phase 2
Not yet recruiting
- Conditions
- Post-traumatic Stress DisorderDepression
- Interventions
- Other: PlaceboDrug: APEX-002-A02
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Apex Labs Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT06141876
News
No news found